Sehgal S, Mujtaba S, Gupta D, Aggarwal R, Marwaha R K
Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):63-7. doi: 10.4103/0377-4929.59186.
Epstein Barr virus (EBV) has a unique association with several human malignancies, especially lymphoproliferative disorders, mainly lymphomas in adults. There is paucity of data pertaining to EBV association with various cancers in India .
The study aims to investigate the association of EBV in childhood leukemia.
Patients attending pediatric oncology services of the referral center have been included in the study. Twenty-five consecutive pediatric patients with acute lymphocytic lukemia (ALL) were subjected to EBV studies employing sensitive polymerase chain reaction followed by hybridization for presence of Bam H1-W region of EBV genome and detection of anti Z EBV replication activator (ZEBRA) antibodies using Western blot. Positive control included a case of Burkitt's lymphoma and infectious mononucleosis each. Raji cells were used as positive control with each test.
The PCR for EBV was positive in 8/25 patients of ALL. Western blot test using anti ZEBRA antibodies was positive in 5/25(20%) cases of ALL. Considering PCR as the gold standard, 32% of the children with ALL had evidence of active EBV replication. The positive controls were consistently positive. None of the 30 healthy laboratory controls, 22 age matched disease controls, 12 cases of AML and 15 cases of multiple myeloma were positive either by PCR or Western blots assays (P < 0. 01). There was no statistically significant correlation between duration of therapy and EBV positivity (P > 0.05).
These studies indicate that a significant number of patients with ALL show evidence of active EBV replication.
爱泼斯坦-巴尔病毒(EBV)与多种人类恶性肿瘤存在独特关联,尤其是淋巴增殖性疾病,主要是成人淋巴瘤。在印度,关于EBV与各种癌症关联的数据较少。
本研究旨在调查EBV与儿童白血病的关联。
本研究纳入了在转诊中心儿科肿瘤服务就诊的患者。连续25例急性淋巴细胞白血病(ALL)患儿接受了EBV研究,采用敏感的聚合酶链反应,随后进行杂交以检测EBV基因组的Bam H1-W区域,并使用蛋白质印迹法检测抗Z EBV复制激活剂(ZEBRA)抗体。阳性对照包括1例伯基特淋巴瘤和1例传染性单核细胞增多症。每次检测均使用Raji细胞作为阳性对照。
ALL患者中8/25的EBV聚合酶链反应呈阳性。使用抗ZEBRA抗体的蛋白质印迹试验在ALL患者中5/25(20%)呈阳性。以聚合酶链反应作为金标准,32%的ALL患儿有EBV活跃复制的证据。阳性对照始终呈阳性。30例健康实验室对照、22例年龄匹配的疾病对照、12例急性髓细胞白血病患者和15例多发性骨髓瘤患者,无论是聚合酶链反应还是蛋白质印迹试验均无阳性结果(P<0.01)。治疗持续时间与EBV阳性之间无统计学显著相关性(P>0.05)。
这些研究表明,相当数量的ALL患者有EBV活跃复制的证据。